ONE SHOT - single shot radiotherapy for localized prostate cancer: 18-month results of a single arm, multicenter phase I/II trial.
Fiche publication
Date publication
février 2024
Journal
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie
Tous les auteurs :
Zilli T, Franzese C, Guckenberger M, Giaj-Levra N, Mach N, Koutsouvelis N, Achard V, McDonald A, Alongi F, Scorsetti M, Constantin G, Bertaut A, Miralbell R
Lien Pubmed
Résumé
To assess in a prospective, multicenter, single-arm phase I/II study the early safety and efficacy profile of single fraction urethra-sparing stereotactic body radiotherapy (SBRT) for men with localized prostate cancer.
Mots clés
Monotherapy, Prostate cancer, SBRT, Single fraction, Toxicity, Urethra-sparing, phase I/II trial
Référence
Radiother Oncol. 2024 02 23;:110181